Table 3.
Adverse events in the atropine groups vs control group during the treatment of myopia in children.
Outcomes | No. of studies | No. of patients |
Odds Ratio (95% CI) |
I2 |
---|---|---|---|---|
Photophobia | 5 RCTs | 388/1,757 vs. 15/2,325 | 16.69 (5.37–51.9) |
70.7% |
9 Cohort | ||||
Blurred near vision | 4 RCTs | 144/1,633 vs. 0 | 17.16 (7.97, 36.95) |
0 |
6 Cohort | ||||
Allergy | 5 RCTs | 49/1,387 vs. 21/1,483 | 2.24 (1.37–3.64) |
77.0% |
2 Cohort |